BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34847963)

  • 1. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement.
    Jacobs JP; Gupta A; Bhatt RR; Brawer J; Gao K; Tillisch K; Lagishetty V; Firth R; Gudleski GD; Ellingson BM; Labus JS; Naliboff BD; Lackner JM; Mayer EA
    Microbiome; 2021 Nov; 9(1):236. PubMed ID: 34847963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
    Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
    Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM; Jaccard J; Keefer L; Brenner DM; Firth RS; Gudleski GD; Hamilton FA; Katz LA; Krasner SS; Ma CX; Radziwon CD; Sitrin MD
    Gastroenterology; 2018 Jul; 155(1):47-57. PubMed ID: 29702118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
    Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.
    Labus JS; Osadchiy V; Hsiao EY; Tap J; Derrien M; Gupta A; Tillisch K; Le Nevé B; Grinsvall C; Ljungberg M; Öhman L; Törnblom H; Simren M; Mayer EA
    Microbiome; 2019 Mar; 7(1):45. PubMed ID: 30898151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits.
    Sarnoff RP; Bhatt RR; Osadchiy V; Dong T; Labus JS; Kilpatrick LA; Chen Z; Subramanyam V; Zhang Y; Ellingson BM; Naliboff B; Chang L; Mayer EA; Gupta A
    Neuropharmacology; 2023 Mar; 225():109381. PubMed ID: 36539012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ
    Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of auricular percutaneous electrical nerve field stimulation on gut microbiome in adolescents with irritable bowel syndrome: A pilot study.
    Bora G; Atkinson SN; Pan A; Sood M; Salzman N; Karrento K
    J Dig Dis; 2023 May; 24(5):348-358. PubMed ID: 37448237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome.
    Mujagic Z; Kasapi M; Jonkers DM; Garcia-Perez I; Vork L; Weerts ZZRM; Serrano-Contreras JI; Zhernakova A; Kurilshikov A; Scotcher J; Holmes E; Wijmenga C; Keszthelyi D; Nicholson JK; Posma JM; Masclee AA
    Gut Microbes; 2022; 14(1):2063016. PubMed ID: 35446234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study.
    Zhou J; Wei H; Zhou A; Xiao X; Xie X; Tang B; Lin H; Tang L; Meng R; Yuan X; Zhang J; Huang C; Huang B; Liao X; Zhong T; He S; Gu S; Yang S
    J Transl Med; 2024 Jan; 22(1):98. PubMed ID: 38263117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of
    Chen L; Xu WL; Pei LX; Wu XL; Geng H; Guo J; Sun JH
    Zhongguo Zhen Jiu; 2021 Feb; 41(2):137-41. PubMed ID: 33788460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.
    Nilholm C; Manoharan L; Roth B; D'Amato M; Ohlsson B
    United European Gastroenterol J; 2022 May; 10(4):363-375. PubMed ID: 35484927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
    Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
    Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
    Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Self-Management Program With Diet Education Does Not Alter Microbiome Characteristics in Women With Irritable Bowel Syndrome.
    Kamp KJ; Plantinga AM; Cain KC; Burr RL; Barney P; Jarrett M; Luna RA; Savidge T; Shulman R; Heitkemper MM
    Biol Res Nurs; 2021 Jul; 23(3):471-480. PubMed ID: 33412896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.